stoxline Quote Chart Rank Option Currency Glossary
  
22nd Century Group, Inc. (XXII)
0.8554  -0.022 (-2.45%)    07-18 16:00
Open: 0.87
High: 0.9082
Volume: 127,095
  
Pre. Close: 0.8769
Low: 0.8361
Market Cap: 7(M)
Technical analysis
2024-07-18 3:24:17 PM
Short term     
Mid term     
Targets 6-month :  1.21 1-year :  1.41
Resists First :  1.03 Second :  1.21
Pivot price 0.76
Supports First :  0.75 Second :  0.57
MAs MA(5) :  0.86 MA(20) :  0.73
MA(100) :  1.48 MA(250) :  9.12
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  80.5 D(3) :  77.9
RSI RSI(14): 53.5
52-week High :  110.23 Low :  0.57
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ XXII ] has closed below upper band by 18.2%. Bollinger Bands are 56.9% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 19 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.91 - 0.92 0.92 - 0.92
Low: 0.83 - 0.84 0.84 - 0.84
Close: 0.87 - 0.88 0.88 - 0.88
Company Description

22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.

Headline News

Mon, 08 Jul 2024
22nd Century Group to Participate in the Emerging Growth Virtual Conference on July 17, 2024 - Newsfile

Wed, 15 May 2024
22nd Century Group Reports First Quarter 2024 Financial Results - Yahoo Finance

Wed, 15 May 2024
22nd Century Group, Inc. (XXII) Q1 2024 Earnings Call Transcript - Seeking Alpha

Tue, 07 May 2024
22nd Century Group (XXII) to Announce First Quarter 2024 Results on May 15, 2024 - Yahoo Finance

Fri, 05 Apr 2024
Is the Rise in 22nd Century Group All Smoke and No Fire? - TheStreet

Fri, 05 Apr 2024
Why 22nd Century Group Stock (XXII) Is Skyrocketing - Benzinga

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Outperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Underperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Consumer Defensive
Industry:
Tobacco
Shares Out 8 (M)
Shares Float 8 (M)
Held by Insiders 7.5 (%)
Held by Institutions 6.3 (%)
Shares Short 307 (K)
Shares Short P.Month 123 (K)
Stock Financials
EPS 109.27
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -3.24
Profit Margin 0 %
Operating Margin -68.6 %
Return on Assets (ttm) -31.3 %
Return on Equity (ttm) -141.5 %
Qtrly Rev. Growth -27.5 %
Gross Profit (p.s.) 0
Sales Per Share 2.33
EBITDA (p.s.) -4.38
Qtrly Earnings Growth 0 %
Operating Cash Flow -40 (M)
Levered Free Cash Flow -15 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value -0.27
Price to Sales 0.36
Price to Cash Flow -0.18
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android